<DOC>
	<DOC>NCT01569282</DOC>
	<brief_summary>Double bypass (hepaticojejunostomy + gastrojejunostomy) is compared to stent strategy in patients planned for curative pancreatic resection in whom peroperative findings makes resection impossible.</brief_summary>
	<brief_title>Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>1. Preoperatively Patients with stent treated tumor in the pancreatic head or periampullary planned for pancreaticoduodenectomy The patient jaundice should have worn off and there should be no signs of duodenal obstruction The patient has given informed consent after verbal and written information in accordance with approved ethics application The patient has no anatomical conditions making endoscopic therapy impossible such as previous Billroth II or Gastric Bypass. 2. Intraoperatively Peroperative findings of of carcinomatosis, metastases or local irresectability who oppose radical surgery Surgical double bypass should be technically feasible The patient has given informed consent after verbal and written information in accordance with approved ethics application Peroperative signs of dysfunction on biliary stent Peroperative findings of gastric outlet obstruction Surgical double bypass not technically feasible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Surgical bypass</keyword>
	<keyword>Hepaticojejunostomy</keyword>
	<keyword>Gastrojejunostomy</keyword>
	<keyword>Biliary stent</keyword>
	<keyword>Enteral stent</keyword>
</DOC>